4//SEC Filing
Wingrove Theresa 4
Accession 0001415889-24-002872
CIK 0000855654other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 9:43 PM ET
Size
11.9 KB
Accession
0001415889-24-002872
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Wingrove Theresa
VP of Regulatory Affairs
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-02-02−21,840→ 32,760 totalExercise: $0.00→ Common Stock (21,840 underlying) - Exercise/Conversion
Common Stock
2024-02-02+29,640→ 33,066 total - Sale
Common Stock
2024-02-05$29.30/sh−12,027$352,391→ 21,039 total - Exercise/Conversion
Restricted Stock Unit
2024-02-02−7,800→ 15,600 totalExercise: $0.00→ Common Stock (7,800 underlying)
Footnotes (5)
- [F1]Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.295 to $29.315, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
- [F3]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F4]The RSUs were awarded on 2/3/2023 and vest with respect to 40% of such RSUs on the one-year anniversary of the date of grant and with respect to the remaining 60% of such RSUs on the eighteen-month anniversary of the date of grant, subject to continued service through each vesting date.
- [F5]The RSUs were awarded on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001510720
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 9:43 PM ET
- Size
- 11.9 KB